IL6 and diabetes mellitus: Finally, studies have demonstrated the existence of a chronic systemic inflammatory state in diabetes, including endothelial dysfunction, platelet hyperactivity, increased inflammatory markers such as C-reactive protein, interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) [68–70].